Abstract
As discussed in previous chapters, lung cancer is one of most deadly diseases and conventional treatments for lung cancer patients are largely ineffective. Presented with at least four major histological types oflung cancers, dependable tools for early detection and diagnosis of each type oflung cancers are urgently needed. This chapter focuses on a high-throughput methodology for identifying new molecular targets in lung cancers and these targets will potentially provide diagnostic and therapeutic values for lung cancer patients (1). Previous studies have reported several lung cancer markers including carcinoembryonic antigen (CEA), urokinase plasminogen activator, squamous cell carcinoma antigen (SCC), cytokeratin 19 fragment (CYFRA 21.1) (2–4), PGP 9.5 (5), and RACS1 (6); however, there is room for much improvement in this area.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang, T., Hopkins, D., Schmidt, C., Silva, S., Houghton, R., Takita, H., et al. (2000) Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 19, 1519–1528.
Pastor, A., Menendez, R., Cremades, M. J., Pastor, V., Llopis, R., and Aznar, J. (1997) Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Euro. Respir. J. 10, 603–609.
Morita, S., Sato, A., Hayakawa, H., Ihara, H., Urano, T., Takada, Y. et al. (1998) Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization. Intl. J. Cancer 78, 286–292.
Brechot, J. M., Chevret, S., Nataf, J., Le Gall, C., Fretault, J., Rochemaure, J., et al. (1997) Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Euro. J. Cancer 33, 385–391.
Hibi, K., Westra, W. H., Borges, M., Goodman, S., Sidransky, D., and Jen, J. (1999) PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am. J. Pathol. 155, 711–715.
Iwasaki, T., Nakashima, M., Watanabe, T., Yamamoto, S., Inoue, Y., Yamanaka, H., et al. (2000) Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Intl. J. Cancer 89, 488–493.
Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.
DeRisi, J., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457–460.
DeRisi, J. L., Iyer, V. R., and Brown, P. O. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680–686.
Iyer, V. R., Eisen, M. B., Ross, D. T., Schuler, G., Moore, T., Lee, J. C., et al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283, 83–87.
Hara, T., Harada, N., Mitsui, H., Miura, T., Ishizaka, T., and Miyajima, A. (1994) Characterization of cell phenotype by a novel cDNA library subtraction system: expression of CD8α in a mast cell-derived interleukin-4-dependent cell line. Blood 84, 189–199.
Schena, M. (ed.) (2000) Microarray Biochip Technology. Eaton Publishing, Natick, MA.
Martinsky, T. and Haje, P. (2000) Microarray tools, kits, reagents, and services, in Microarray Biochip Technology (Schena, M., ed.), Eaton Publishing, Natick, MA, pp. 201–220.
Schena, M., ed. (2000) DNA Microarrays A Practical Approach. Oxford University Press, New York, NY.
Brown, P. O. http://cmgm.stanford.edu/pbrown
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Wang, T., Reed, S.G. (2003). A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-324-0:177
Download citation
DOI: https://doi.org/10.1385/1-59259-324-0:177
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-920-9
Online ISBN: 978-1-59259-324-8
eBook Packages: Springer Protocols